Simplex Trading’s Marker Therapeutics MRKR Stock Holding History

Simplex Trading’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,900	Closed	-$32K	–	10524
2022 Q2	$32K	Hold	9,900	–	–	﹤0.01%	7063
2022 Q1	$43K	Buy	+9,900	New	+$56.6K	﹤0.01%	7344
2021 Q4	–	Sell	-8,640	Closed	-$248K	–	11055
2021 Q3	$248K	Sell	8,640 -80	-0.9%	-$1.64K	﹤0.01%	5246
2021 Q2	$243K	Buy	8,720 +8,694	+33,438%	+$229K	﹤0.01%	5362
2021 Q1	$57K	Buy	+26	New	+$595	﹤0.01%	6444
2020 Q3	–	Sell	-7	Closed	-$14K	–	8202
2020 Q2	$14K	Sell	7 -6	-46%	-$131	﹤0.01%	6450
2020 Q1	$23K	Sell	13 -4	-24%	-$102	﹤0.01%	5835
2019 Q4	$48K	Buy	17 +5	+42%	+$182	﹤0.01%	5223
2019 Q3	$61K	Sell	12 -2	-14%	-$118	﹤0.01%	4820
2019 Q2	$112K	Buy	+14	New	+$832	﹤0.01%	4066

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AAM

AR Asset Management West Hollywood, California $517M AUM 18.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MAA

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's MRKR Position: Q1 2023 in Review

Simplex Trading sold out of Marker Therapeutics (MRKR) in Q1 2023, closing a stake of 16 shares.

Simplex Trading first reported a position in MRKR in Q1 2019 and held it in 12 quarters. The position peaked at $183K in Q1 2021. 30 funds tracked by Wall St. Rank hold MRKR as of Q1 2023.

Simplex Trading reported no remaining Marker Therapeutics position as of Q1 2023 after selling out during the quarter.
Simplex Trading sold 16 Marker Therapeutics shares in Q1 2023.
Simplex Trading first reported a position in Marker Therapeutics in Q1 2019 and held it in 12 quarters.
Simplex Trading's Marker Therapeutics position peaked at $183K in Q1 2021.
30 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.